CIBC Private Wealth Group
MRNA icon

CIBC Private Wealth Group’s Moderna MRNA Stock Holding History

CIBC Private Wealth Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$158K Sell
5,344
-2,295
-30% -$62.4K ﹤0.01% 1308
2025
Q3 		$197K Sell
7,639
-756
-9% -$21.1K ﹤0.01% 1185
2025
Q2 		$232K Buy
8,395
+1,669
+25% +$44K ﹤0.01% 1060
2025
Q1 		$166K Sell
6,726
-320
-5% -$11.4K ﹤0.01% 1149
2024
Q4 		$304K Buy
7,046
+2,979
+73% +$142K ﹤0.01% 1008
2024
Q3 		$272K Sell
4,067
-924
-19% -$84.8K ﹤0.01% 1057
2024
Q2 		$581K Sell
4,991
-1,857
-27% -$235K ﹤0.01% 781
2024
Q1 		$723K Buy
6,848
+3,980
+139% +$401K ﹤0.01% 746
2023
Q4 		$285K Sell
2,868
-479
-14% -$40.3K ﹤0.01% 952
2023
Q3 		$346K Buy
3,347
+1,363
+69% +$152K ﹤0.01% 844
2023
Q2 		$241K Sell
1,984
-345
-15% -$46K ﹤0.01% 808
2023
Q1 		$358K Sell
2,329
-8,244
-78% -$1.36M ﹤0.01% 756
2022
Q4 		$1.9K Buy
10,573
+8,496
+409% +$1.39M ﹤0.01% 754
2022
Q3 		$246K Sell
2,077
-140
-6% -$21.2K ﹤0.01% 823
2022
Q2 		$316K Sell
2,217
-5,431
-71% -$776K ﹤0.01% 788
2022
Q1 		$1.32M Buy
7,648
+5,393
+239% +$908K ﹤0.01% 596
2021
Q4 		$573K Sell
2,255
-1,042
-32% -$305K ﹤0.01% 744
2021
Q3 		$1.27M Buy
3,297
+645
+24% +$238K ﹤0.01% 576
2021
Q2 		$623K Buy
2,652
+80
+3% +$14.3K ﹤0.01% 764
2021
Q1 		$337K Buy
2,572
+34
+1% +$4.93K ﹤0.01% 881
2020
Q4 		$265K Buy
+2,538
New +$257K ﹤0.01% 893
2020
Q2 		– Sell
-23,763
Closed -$712K – 731
2020
Q1 		$712K Buy
+23,763
New +$547K ﹤0.01% 563

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CIBC Private Wealth Group's MRNA Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Moderna (MRNA) stake by 30% in Q4 2025, selling an estimated $62.4K and leaving 5,344 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

CIBC Private Wealth Group first reported a position in MRNA in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.32M in Q1 2022. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • CIBC Private Wealth Group held 5,344 shares of Moderna worth $158K as of Q4 2025.
  • CIBC Private Wealth Group sold 2,295 Moderna shares in Q4 2025, an estimated $62.4K.
  • Moderna made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1308 holding.
  • CIBC Private Wealth Group first reported a position in Moderna in Q1 2020 and has held it in 22 quarters since.
  • CIBC Private Wealth Group's Moderna position peaked at $1.32M in Q1 2022.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.